Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 open-label single-arm on-demand study of human coagulation factor VIII for bleeding episodes in hemophilia A
CTR20242208Phase 3Active
- Sponsor
- Sichuan Yuanda Shuyang Pharmaceutical
- Start
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of antihemophilic factor human in hemophilia A, sponsored by Sichuan Yuanda Shuyang Pharmaceutical. Started Jul 2024; status: active.
02
Drugs
antihemophilic factor human
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20242208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242208.